Craig Muir
Interim Chief Technology Officer at Pliant Therapeutics · Previously invested at Third Rock Ventures
Investments
3
Lead Investments
3
Highlights
Focus Areas
Biotechnology
Therapeutics
Genetics
Health Care
Health Diagnostics
Firms Invested Under
Recent Investments
